31
Antipsychotics / Neuroleptics / Re: Everything You Need to Know About Olanzapine
« Last post by smfadmin on May 01, 2026, 06:53:19 AM »Here is another story on this antipsychotic ...
i=Bg6UgYBbgJNxNKCN

|
31
Antipsychotics / Neuroleptics / Re: Everything You Need to Know About Olanzapine« Last post by smfadmin on May 01, 2026, 06:53:19 AM »Here is another story on this antipsychotic ...
i=Bg6UgYBbgJNxNKCN 32
Antipsychotics / Neuroleptics / Everything You Need to Know About Olanzapine« Last post by Chip on May 01, 2026, 06:50:22 AM »In this video, they discuss the top 7 things you need to know about olanzapine or Zyprexa. We discuss what olanzapine is, what it is used for, how long it takes to work, whether olanzapine is addicting, the side effects, drug interactions, and my final thoughts.
i=YRJ7yW_WvequtEHI 33
Ethnobotanicals / Ephedra Supply Chain, Harvesting, and Where Illicit Diversion Actually Happens« Last post by smfadmin on May 01, 2026, 05:22:38 AM »Ephedra Supply Chain, Traditional Harvesting, and Where Illicit Diversion Actually Happens
1. The plant and where it grows Ephedra (Ephedra) is a hardy desert shrub found in: - Northern China (Inner Mongolia, Xinjiang, Gansu) - Mongolia - Central Asia (Kazakhstan, Kyrgyzstan) - Parts of the Middle East and North Africa It grows in: - Dry, sandy or rocky soils - Steppe and desert climates - Areas where normal agriculture is difficult or impossible It is not a cultivated high-yield crop in most cases. It survives wild rather than being intensively farmed. --- 2. Who actually collects it The people involved are typically: - Rural foragers in arid regions - Small-scale traditional herbal collectors - Seasonal harvest workers supplying herbal trade networks They are not industrial producers. The activity is closer to wild plant gathering than farming. --- 3. How harvesting is done The process is simple and manual: - Cutting stems by hand using knives or sickles - Bundling plant material - Sun-drying in open air - Basic sorting by appearance and quality There is no chemical processing at this stage. It is raw botanical handling only. --- 4. Where it goes next (legal supply chain) After harvest: - Local traders buy bulk dried material - It moves to regional herbal markets - Large wholesalers distribute it into Traditional Chinese Medicine (TCM) networks - Some is processed into extracts or formulations in regulated facilities Historically, Ephedra was used directly in herbal medicine systems, but modern regulation has reduced its direct use in many countries. --- 5. Key chemical relevance Ephedra contains: - Ephedrine - Pseudoephedrine These compounds affect adrenergic signaling and have stimulant and bronchodilator effects. They are the pharmacological reason the plant became controlled. --- 6. Where illicit diversion actually happens This is the critical point people often misunderstand: The plant itself is rarely the direct source in modern illicit activity. Instead, diversion typically occurs here: - Pharmaceutical manufacturing (cold/flu tablets containing pseudoephedrine) - Pharmacy retail diversion (bulk purchasing and extraction attempts) - Controlled chemical supply chains Why this shift happened: - Tablets contain predictable, high-concentration precursor - Wild Ephedra has variable and lower alkaloid content - Industrial control and enforcement make plant processing inefficient So the real bottleneck is not harvesting plants in deserts—it is access to regulated pharmaceutical precursors. --- 7. Why Ephedra is historically linked to this issue Ephedra matters because: - It naturally produces ephedrine-type alkaloids - Those compounds are chemically active in stimulant pathways - Early extraction routes were explored historically before regulation tightened But in modern reality, it is mostly a regulatory origin story, not an operational supply source. --- 8. Summary - Ephedra is mostly wild-harvested by rural collectors in arid regions - It moves through herbal medicine supply chains, not industrial farming systems - The illicit relevance is not the plant itself, but its active alkaloids - Modern diversion overwhelmingly involves pharmaceutical pseudoephedrine, not raw plant material 34
Phenethylamines / Ephedra Plant (Ma Huang): Overview, Uses, Chemistry, and Illicit Diversion« Last post by Chip on May 01, 2026, 05:15:25 AM »Ephedra (Ma Huang) Plant: Uses, Chemistry, and Illicit Diversion
1. What Ephedra is Ephedra (Ephedra) is a group of desert-adapted shrubs found across Asia, the Middle East, North Africa, and parts of the Americas. In Traditional Chinese Medicine it is known as Ma Huang and has been used for thousands of years. It looks like thin, green, jointed stems rather than a leafy plant. 2. Active compounds The main active alkaloids are: - Ephedrine - Pseudoephedrine These compounds stimulate the sympathetic nervous system. 3. Effects on the body Ephedrine-type compounds typically cause: - Increased heart rate - Increased blood pressure - Airway opening (bronchodilation) - Increased alertness and reduced fatigue 4. Traditional medicinal use Historically used for: - Asthma relief - Nasal congestion - Cough suppression - Short-term stimulation in herbal formulas It is usually combined with other herbs due to its potency. 5. Legal status Because ephedrine and pseudoephedrine can be diverted into illegal drug production pathways, regulations are strict: - Banned or restricted in many countries as supplements - Pseudoephedrine sold only in controlled pharmacy settings in places like Australia - Ephedrine tightly controlled or prescription-only 6. Illicit diversion (high-level overview only) Compounds from Ephedra have been misused as precursors in illegal stimulant drug production. This involves chemical conversion processes carried out in illicit laboratories. No technical details are provided here. 7. Risks Even medically, these compounds can cause: - Cardiovascular stress - High blood pressure - Arrhythmias - Anxiety and insomnia - Serious risk of stroke or heart events in vulnerable people Risk increases significantly with higher doses or stimulant combinations. 8. Summary Ephedra is a pharmacologically active plant with strong stimulant effects. It has a long medicinal history but is heavily regulated today due to its abuse potential and cardiovascular risks. 35
Ethnobotanicals / Ephedra (Ma Huang): Chemistry, Pharmacology, and Regulation« Last post by smfadmin on May 01, 2026, 05:11:21 AM »Ephedra (Ma Huang): Chemistry, Pharmacology, and Regulation
Overview Ephedra is a genus of xerophytic (dry-climate) shrubs found across Asia, the Middle East, Europe, and the Americas. Several species have been used in traditional medicine, particularly in China, where it is known as "ma huang." Primary Active Compounds Ephedra species contain phenethylamine-class alkaloids, mainly:
These compounds are structurally related to endogenous catecholamines and synthetic stimulants. Basic Structural Notes
Pharmacology Ephedrine-type alkaloids act as mixed-acting sympathomimetics:
Physiological effects:
Traditional Use
Modern Medical Use
Safety and Toxicology Adverse effects increase with dose and stimulant stacking:
Risk factors include:
Regulatory Status Due to safety concerns and misuse potential:
Illicit Drug Context (High-Level) Ephedrine and pseudoephedrine are chemically related to amphetamine-class stimulants. This structural similarity has led to:
(No synthesis or process information provided.) Harm Reduction Notes
Bottom Line Ephedra is a natural source of sympathomimetic alkaloids with legitimate historical and medical uses. However, its risk profile and chemical relationship to stronger stimulants have led to strict modern regulation. 36
Phenethylamines / Amphetamine and Meth Differentially Affect Dopamine Transporters« Last post by Chip on May 01, 2026, 04:34:28 AM »Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo
https://acrobat.adobe.com/id/urn:aaid:sc:AP:c407b973-a6e8-41df-81a2-e287367d79e6 The psychostimulants D-amphetamine (AMPH) and methamphetamine (METH) release excess dopamine (DA) into the synaptic clefts of dopaminergic neurons. Abnormal DA release is thought to occur by reverse transport through the DA transporter (DAT), and it is believed to underlie the severe behavioral effects of these drugs. Here we compare structurally similar AMPH and METH on DAT function in a heterologous expression system and in an animal model. In the in vitro expression system, DAT-mediated whole-cell currents were greater for METH stimulation than for AMPH. At the same voltage and concentration, METH released five times more DA than AMPH and did so at physiological membrane potentials. 37
In the Media / My healthy fruiting meth pipe plant, lol« Last post by Chip on May 01, 2026, 03:43:06 AM »![]() Courtesy of a funny trans girl baiting a drug selling scammer and AI. Attachments: copilot_image_1777577800246.jpeg 38
Synthetics / Other / 7-OH-Mitragynine–Induced Psychosis and Delirium« Last post by smfadmin on April 18, 2026, 06:06:07 PM »https://www.psychiatrist.com/pcc/7-oh-mitragynine-induced-psychosis-delirium/?utm_source=Klaviyo&utm_medium=email&utm_campaign=FOM_New_4%2F17&klid=01HYSTTNXNB74YAYKT9XMYQCN0&_kx=va3uRF3O8-7Dg_zjrKMZJk0wdery-TOTVyZ3l8muM1g.VpkqxC
7-OH-Mitragynine–Induced Psychosis and Delirium April 14, 2026 Mitragyna speciosa is a tropical tree native to Southeast Asia, the leaves of which are commonly known as kratom. 7-Hydroxymitragynine (7-OH) is a substance derived from kratom leaves and is marketed as a distinct product. Although its full properties are poorly understood, 7-OH’s known opioid-like effects and unregulated status in the United States have resulted in more widespread recreational use. As 7-OH use gains prevalence, it becomes increasingly important to understand its constellation of adverse effects. We present the case of a patient who, following several months of heavy 7-OH use, developed psychosis and delirium that persisted for nearly a week following cessation. The patient was medically hospitalized and required several days of opioid withdrawal management and supportive care before returning to his baseline mental status. The case report can be found at the link above ... 39
Health Issues and Medical / Experimental Drug Can Reverse Osteoarthritis in Weeks, Animal Research Shows« Last post by Chip on April 14, 2026, 04:00:33 AM »https://share.google/1J5UBL1m0k9PgmhJC
Take the link to see the video ! Experimental Drug Can Reverse Osteoarthritis in Weeks, Animal Research Shows 12 April 2026 The debilitating, chronic loss of joint cartilage known as osteoarthritis causes pain and bone decay for hundreds of millions of people every day, but new help may be on the way – in the form of a simple, single shot. Based on ongoing animal experiments, injecting a carefully engineered, slow-release drug-delivery system into the damaged joint can coax the body's own cartilage and bone cells to carry out an effective repair job in just a few weeks. "In two years, we were able to go from a moonshot idea to developing these therapies to demonstrating that they reverse osteoarthritis in animals," says chemical and biological engineer Stephanie Bryant, from the University of Colorado (UC) Boulder. Having completed the first tranche of the animal experiments, the team is ready to move on to phase two. This will gather further data on safety and toxicology, laying the groundwork for human clinical trials. "Our goal," says Bryant, "is not just to treat pain and halt progression, but to end this disease." Right now, there is no cure for osteoarthritis: Either the pain has to be managed, or the joint has to be replaced with a metal or plastic substitute. The research underway here (and not yet peer reviewed) potentially points to a solution that rallies the body's own cells to repair damaged joints. Besides their drug delivery system, the team is developing an injectable 'implant' that sets in place and recruits the body's cells to patch up gaps in cartilage. Ultimately, the aim is to have different options for different stages of the condition. There are actually four stages of osteoarthritis, from early and mild cartilage loss to a complete lack of cartilage and intense pain as bone meets bone – this is where the stiffness, swelling, and inflammation will be at its worst. "At the moment, the options for many patients are either a massive, expensive surgery or nothing," says Evalina Burger, a professor and chair of the Department of Orthopedics at UC Anschutz. i=bim5NvInNm5DLoxs "There's not a lot in between." Considering how common osteoarthritis is, how painful it can be, and how much it limits mobility and day-to-day life, there are now numerous research efforts underway looking at treatment options. The amount of cartilage in our joints naturally decreases over time, but regular exercise is one way you can protect against this. Stronger muscles reduce the strain on joints, and movement pushes nutrient-rich fluids through them. The article continues at the link ... Attachments: KneePain-600x338.webp 40
Music / Peter McNamara 10pm til 12.30am @ The Social 10/05/25« Last post by Chip on April 12, 2026, 01:05:17 PM » |
